By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Multikinase inhibitors > Dabrafenib > Dabrafenib Side Effects
Multikinase inhibitors

Dabrafenib Side Effects

Summary

Commonly reported side effects of dabrafenib include: squamous cell carcinoma, fever, and hyperglycemia. Other side effects include: keratoacanthoma. Continue reading for a comprehensive list of adverse effects.

Applies to dabrafenib: oral capsule, oral tablet for suspension.

Serious side effects of Dabrafenib

Along with its needed effects, dabrafenib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking dabrafenib:

More common

  • Bleeding gums
  • bloody, black, or tarry stools
  • bloody or cloudy urine
  • blurred vision
  • coughing up blood
  • difficulty in breathing or swallowing
  • dizziness
  • dry mouth
  • fever
  • flushed, dry skin
  • fruit-like breath odor
  • greatly decreased frequency of urination or amount of urine
  • headache
  • heartburn
  • increased hunger
  • increased thirst
  • increased urination
  • indigestion
  • lump or growth on the skin
  • nausea
  • nosebleed
  • prolonged bleeding from cuts
  • red or black, tarry stools
  • red or dark brown urine
  • redness, swelling, or pain of the skin
  • scaling of the skin on the hands and feet
  • skin blisters
  • skin rash
  • stomach pain or cramps
  • sweating
  • swelling of the feet or lower legs
  • tingling of the hands and feet
  • ulceration of the skin
  • unable to move
  • unexplained weight loss
  • unusual tiredness or weakness
  • vomiting
  • vomiting of material that looks like coffee grounds, severe and continuing

Less common

  • Blurred vision or other change in vision
  • change in color vision
  • difficulty seeing at night
  • eye pain
  • increased sensitivity of the eyes to sunlight
  • redness of the eye
  • tearing

Incidence not known

  • Blistering, peeling, loosening of the skin
  • chills
  • cough
  • diarrhea
  • itching
  • joint or muscle pain
  • red skin lesions, often with a purple center
  • sore throat
  • sores, ulcers, or white spots in the mouth or on lips
  • swollen, painful, or tender lymph glands in the neck, armpit, or groin
  • yellow eyes or skin

Other side effects of Dabrafenib

Some side effects of dabrafenib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Acne, pimples
  • back pain
  • bloating
  • difficulty having a bowel movement
  • fast heartbeat
  • hair loss or thinning of the hair
  • loosening of the fingernails
  • loss of appetite
  • muscle ache or stiffness
  • pains in the stomach, side, or abdomen, possibly radiating to the back
  • redness or soreness around the fingernails
  • stuffy or runny nose

For Healthcare Professionals

Applies to dabrafenib: oral capsule, oral tablet soluble.

Metabolic

Very common (10% or more): Hyperglycemia (71%), hypophosphatemia (38%), decreased appetite (29%), hyponatremia (57%)

Common (1% to 10%): Dehydration[Ref]

Hepatic

Very common (10% or more): Increased alkaline phosphatase (64%), increased AST (61%), increased ALT (38%)

Common (1% to 10%): Increased gamma-glutamyltransferase, hyperbilirubinemia[Ref]

Other

Very common (10% or more): Pyrexia (55%), fatigue/asthenia/malaise (51%), chills (31%), edema (28%)

Common (1% to 10%): Influenza-like illness, mucosal inflammation[Ref]

Hematologic

Very common (10% or more): Leukopenia (48%), anemia (46%), neutropenia (44%), lymphopenia (42%)

Common (1% to 10%): Thrombocytopenia[Ref]

Gastrointestinal

Very common (10% or more): Nausea (45%), vomiting (33%), diarrhea (32%), constipation (13%), abdominal pain (11%)

Common (1% to 10%): Dry mouth, stomatitis

Uncommon (0.1% to 1%): Pancreatitis, gastrointestinal perforation, colitis[Ref]

Dermatologic

Very common (10% or more): Hyperkeratosis (37%), rash (32%), dry skin (31%), alopecia (22%), palmar-plantar erythrodysesthesia syndrome (20%), pruritus, erythema

Common (1% to 10%): Actinic keratosis, skin lesion, photosensitivity reaction, cellulitis, folliculitis, paronychia, pustular rash, dermatitis acneiform, night sweats, hyperhidrosis, panniculitis, skin fissures

Uncommon (0.1% to 1%): Serious skin toxicity

Frequency not reported: Bullous rash[Ref]

Nervous system

Very common (10% or more): Headache (32%), dizziness (11%)[Ref]

Musculoskeletal

Very common (10% or more): Arthralgia (27%), myalgia (15%), pain in extremity (14%), back pain (12%), muscle spasms

Common (1% to 10%): Increased creatine phosphokinase

Uncommon (0.1% to 1%): Rhabdomyolysis[Ref]

Oncologic

Very common (10% or more): Papilloma (27%)

Common (1% to 10%): Cutaneous squamous cell carcinoma/keratoacanthoma/Bowen's disease, basal cell carcinoma, seborrheic keratosis, acrochordon

Uncommon (0.1% to 1%): New primary melanoma[Ref]

Cardiovascular

Very common (10% or more): Hemorrhage (23%), hypertension (22%)

Common (1% to 10%): Cardiomyopathy/decreased left ventricular ejection fraction, hypotension, lymphedema, bradycardia

Uncommon (0.1% to 1%): QT prolongation, cardiac failure

Frequency not reported: Myocarditis[Ref]

Respiratory

Very common (10% or more): Cough (22%), dyspnea (20%), nasopharyngitis (12%)

Common (1% to 10%): Interstitial lung disease/pneumonitis

Frequency not reported: Respiratory distress[Ref]

Renal

Very common (10% or more): Increased creatinine (21%)

Common (1% to 10%): Renal failure

Uncommon (0.1% to 1%): Acute renal failure, nephritis

Frequency not reported: Interstitial nephritis[Ref]

Genitourinary

Very common (10% or more): Urinary tract infection[Ref]

Ocular

Common (1% to 10%): Uveitis, blurred vision, vision impairment

Uncommon (0.1% to 1%): Chorioretinopathy, retinal detachment, periorbital edema[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by